The treatment of difficult intrahepatic duct stones has emerged as a critical area of inquiry due to the high prevalence and complex management challenges of hepatolithiasis worldwide. Epidemiological data indicate that hepatolithiasis affects up to 50% of patients in East Asia and presents increasing incidence in Western countries, emphasizing the global relevance of effective treatment strategies(